An epistatic interaction controls the latency of a transgene-induced mammary tumor

被引:43
作者
Le Voyer, T
Lu, ZC
Babb, J
Lifsted, T
Williams, M
Hunter, K
机构
[1] Fox Chase Canc Ctr, Biostat Facil, Philadelphia, PA 19111 USA
[2] Fox Chase Canc Ctr, Div Populat Sci, Philadelphia, PA 19111 USA
关键词
D O I
10.1007/s003350010163
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous studies from our laboratory demonstrated that the latency, tumor growth, and metastatic progression of polyoma middle T-induced mammary tumor in an FVB/NJ inbred mouse background could be significantly altered by the introduction of different genetic backgrounds. In this study we extend these findings by mapping a number of interacting quantitative trait loci responsible for the changes in phenotype. Introduction of the I/LnJ inbred genetic background into the FVB/NJ-PyMT animal significantly accelerated the appearance of the primary tumor (35 vs. 57 days postnatal, p < 10(-7)). A backcross mapping panel was established, and loci responsible for the tumor acceleration were detected on Chrs 15 and 9. Examination of the genotype/phenotype correlation revealed that the FVB/NJ but not the I/LnJ allele of the Chr 15 locus was associated with tumor acceleration and was conditional on the presence of I/LnJ allele on Chr 9. These loci, designated Apmt1 and Apmt2, map to homologous regions associated with LOH in human breast cancer. These results suggest that allelic variants of genes in these regions may contribute to age of onset in human breast cancer.
引用
收藏
页码:883 / 889
页数:7
相关论文
共 39 条
[1]  
Anbazhagan R, 1998, AM J PATHOL, V152, P815
[2]   FAMILIAL RISK, ABORTION AND THEIR INTERACTIVE EFFECT ON THE RISK OF BREAST-CANCER - A COMBINED ANALYSIS OF 6 CASE-CONTROL STUDIES [J].
ANDRIEU, N ;
DUFFY, SW ;
ROHAN, TE ;
LE, MG ;
LUPORSI, E ;
GERBER, M ;
RENAUD, R ;
ZARIDZE, DG ;
LIFANOVA, Y ;
DAY, NE .
BRITISH JOURNAL OF CANCER, 1995, 72 (03) :744-751
[3]   Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer [J].
Athma, P ;
Rappaport, R ;
Swift, M .
CANCER GENETICS AND CYTOGENETICS, 1996, 92 (02) :130-134
[4]  
Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4
[5]   GENETIC ALTERATIONS IN BREAST-CANCER [J].
BIECHE, I ;
LIDEREAU, R .
GENES CHROMOSOMES & CANCER, 1995, 14 (04) :227-251
[6]  
DIETRICH W, 1992, GENETICS, V131, P423
[7]  
Doerge RW, 1996, GENETICS, V142, P285
[8]   Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13 [J].
Easton, DF ;
Steele, L ;
Fields, P ;
Ormiston, W ;
Averill, D ;
Daly, PA ;
McManus, R ;
Neuhausen, SL ;
Ford, D ;
Wooster, R ;
CannonAlbright, LA ;
Stratton, MR ;
Goldgar, DE .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (01) :120-128
[9]  
EASTON DF, 1993, AM J HUM GENET, V52, P678
[10]  
FORD D, 1995, AM J HUM GENET, V57, P1457